• Targeting Pain

  • Dec 5 2022
  • Duración: 12 m
  • Podcast
  • Resumen

  • Quána Madison is one of the millions of Americans living with chronic pain. Dressing herself or even showering can be excruciating. Dr. Paul Negulescu and the research team at Vertex are thinking differently about pain – they’re investigating potential non-opioid based treatment options that aim to target pain where it starts. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. 

     

    Featured guests:

    Quána Madison is an artist, mindfulness teacher, healing arts workshop facilitator, self-leadership coach, model and artist-philanthropist. She lives with chronic pain.

    Norm Buckley is the Scientific Director of the Michael G. DeGroote Institute for Pain Research and Care at McMaster University. 

    David Altshuler is the Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals.

    Paul Negulescu is a renowned cystic fibrosis researcher and now the Senior Vice President leading the team researching pain at Vertex Pharmaceuticals.

    Read more about Vertex's approach to targeting pain.
     

    Más Menos

Lo que los oyentes dicen sobre Targeting Pain

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.